Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome) (Q34016144)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome)	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome) (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Temmy Sunyoto

8

0 references

object named as

Sakib Burza

1

0 references

Johan van Griensven

4

object named as

Johan van Griensven

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Raman Mahajan

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Prabhat K Sinha

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Krishna Pandey

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

María Angeles Lima

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marta Gonzalez Sanz

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sunil Kumar

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gaurab Mitra

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ranjeet Kumar

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Neena Verma

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pradeep Das

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

7 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PLoS Neglected Tropical Diseases

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

e3053

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

copyright license

Creative Commons Attribution 4.0 International

7 August 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Clinical aspects of visceral leishmaniasis in HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Liposomal amphotericin B as a treatment for human leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Estimate of HIV prevalence and number of people living with HIV in India 2008-2009.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Combination therapy for visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Competing risk regression models for epidemiologic data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

The relationship between leishmaniasis and AIDS: the second 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Visceral leishmaniasis/human immunodeficiency virus co-infection in India: the focus of two epidemics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Laboratory diagnosis of visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Epidemiology of visceral leishmaniasis in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

5 July 2018

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003053

21 January 2018

Non-parametric inference for cumulative incidence functions in competing risks studies.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003053

21 January 2018

Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003053

21 January 2018

Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003053

21 January 2018

One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003053

21 January 2018

Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003053

21 January 2018

Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125300

29 October 2018

Leishmania–HIV co-infection: An emerging problem in India

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003053

21 January 2018

Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India

1 reference

https://pubmed.ncbi.nlm.nih.gov/25101665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visceral Leishmaniasis and HIV Coinfection in Bihar, India

1 reference

https://pubmed.ncbi.nlm.nih.gov/25101665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kala-Azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25101665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0003053

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34016144&oldid=1860937547"